4-isoxazolyl-1,4-dihydropyridines: a tale of two scaffolds
- PMID: 24962283
- DOI: 10.4155/fmc.14.46
4-isoxazolyl-1,4-dihydropyridines: a tale of two scaffolds
Abstract
The association of the isoxazole and dihydropyridine (DHP) ring systems fused at the 4'-isoxazolyl- to the 4-position of the DHP has produced a combination scaffold, the isoxazolyl-DHPs (IDHPs) with unique conformational characteristics. The IDHPs are useful in probing biological activity, as exemplified by our efforts in the fields of voltage gated calcium channel (VGCC) antagonists and inhibitors of the multi-drug resistance (MDR) transporter. A strategically placed methyl group produced a signifcant change at the VGCC, with (R)-(+)-1-phenyl-prop-2-yl (3.7 nM) > phenethyl (22.9 nM) > (S)-(-)-1-phenyl-prop-2-yl (210 nM), a eudismic ratio of 56.7. Branching at the C-5 of the isoxazole produced a 25% increase in MDR binding, and replacing the DHP C-3 ester with a functionalized amide also gave a dramatic increase in binding affinity. Opportunities for combined scaffolds - including examples containing IDHPs - are waiting to be discovered: because new biology is driven by new chemistry.
Similar articles
-
Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter.Bioorg Med Chem. 2017 Jun 15;25(12):3223-3234. doi: 10.1016/j.bmc.2017.04.008. Epub 2017 Apr 8. Bioorg Med Chem. 2017. PMID: 28434782 Free PMC article.
-
4-Isoxazolyl-1,4-dihydropyridines exhibit binding at the multidrug-resistance transporter.Bioorg Med Chem. 2012 Nov 15;20(22):6613-20. doi: 10.1016/j.bmc.2012.09.022. Epub 2012 Sep 25. Bioorg Med Chem. 2012. PMID: 23063517 Free PMC article.
-
4-Isoxazolyl-1,4-dihydropyridines: biological, theoretical, and structural studies.J Med Chem. 1990 Aug;33(8):2255-9. doi: 10.1021/jm00170a032. J Med Chem. 1990. PMID: 2142737
-
Fused 1,4-dihydropyridines as potential calcium modulatory compounds.Mini Rev Med Chem. 2006 Jul;6(7):747-55. doi: 10.2174/138955706777698606. Mini Rev Med Chem. 2006. PMID: 16842124 Review.
-
Dihydropyridines and multidrug resistance: previous attempts, present state, and future trends.Chem Biol Drug Des. 2010 Nov;76(5):369-81. doi: 10.1111/j.1747-0285.2010.01025.x. Chem Biol Drug Des. 2010. PMID: 20925689 Review.
Cited by
-
Synthesis and crystal structures of a bis-(3-hy-droxy-cyclo-hex-2-en-1-one) and two hexa-hydro-quinoline derivatives.Acta Crystallogr E Crystallogr Commun. 2020 Jan 3;76(Pt 2):125-131. doi: 10.1107/S2056989019017018. eCollection 2020 Feb 1. Acta Crystallogr E Crystallogr Commun. 2020. PMID: 32071733 Free PMC article.
-
Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter.Bioorg Med Chem. 2017 Jun 15;25(12):3223-3234. doi: 10.1016/j.bmc.2017.04.008. Epub 2017 Apr 8. Bioorg Med Chem. 2017. PMID: 28434782 Free PMC article.
-
Lanthanide and asymmetric catalyzed syntheses of sterically hindered 4-isoxazolyl-1,4-dihydropyridines and 4-isoxazolyl-quinolones.Tetrahedron Lett. 2016 Jan 20;57(3):423-425. doi: 10.1016/j.tetlet.2015.12.038. Tetrahedron Lett. 2016. PMID: 26783372 Free PMC article. No abstract available.
-
PF-06526290 can both enhance and inhibit conduction through voltage-gated sodium channels.Br J Pharmacol. 2018 Jul;175(14):2926-2939. doi: 10.1111/bph.14338. Epub 2018 Jun 3. Br J Pharmacol. 2018. PMID: 29791744 Free PMC article.
-
Addition of a single methyl group to a small molecule sodium channel inhibitor introduces a new mode of gating modulation.Br J Pharmacol. 2015 Oct;172(20):4905-18. doi: 10.1111/bph.13259. Epub 2015 Oct 15. Br J Pharmacol. 2015. Retraction in: Br J Pharmacol. 2018 Jul;175(13):2712. doi: 10.1111/bph.14349. PMID: 26220736 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous